Woodley Farra Manion Portfolio Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$219K Hold
1,269
0.01% 117
2025
Q4
$253K Buy
+1,269
New +$230K 0.01% 103
2025
Q3
Sell
-1,407
Closed -$213K 120
2025
Q2
$213K Sell
1,407
-722
-34% -$96.3K 0.01% 111
2025
Q1
$320K Sell
2,129
-434
-17% -$72.8K 0.02% 90
2024
Q4
$473K Sell
2,563
-232,588
-99% -$44.8M 0.02% 78
2024
Q3
$46.3M Sell
235,151
-4,620
-2% -$960K 2.33% 22
2024
Q2
$49.5M Sell
239,771
-3,389
-1% -$768K 2.69% 20
2024
Q1
$65.9M Buy
243,160
+137,120
+129% +$32.7M 3.63% 9
2023
Q4
$25.1M Buy
106,040
+169
+0.2% +$33.2K 1.5% 29
2023
Q3
$20.7M Sell
105,871
-1,187
-1% -$244K 1.38% 28
2023
Q2
$22.5M Buy
107,058
+2,253
+2% +$448K 1.45% 30
2023
Q1
$21.2M Buy
+104,805
New +$23.8M 1.44% 30

Other funds holding CRL

Woodley Farra Manion Portfolio Management's CRL Position: Q1 2026 in Review

Woodley Farra Manion Portfolio Management held its Charles River Laboratories (CRL) position steady in Q1 2026 at 1,269 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #117.

Woodley Farra Manion Portfolio Management first reported a position in CRL in Q1 2023 and has held it in 12 quarters since. The position peaked at $65.9M in Q1 2024. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Woodley Farra Manion Portfolio Management held 1,269 shares of Charles River Laboratories worth $219K as of Q1 2026.
  • Woodley Farra Manion Portfolio Management left its Charles River Laboratories share count unchanged in Q1 2026.
  • Charles River Laboratories made up 0.01% of Woodley Farra Manion Portfolio Management's portfolio in Q1 2026, its #117 holding.
  • Woodley Farra Manion Portfolio Management first reported a position in Charles River Laboratories in Q1 2023 and has held it in 12 quarters since.
  • Woodley Farra Manion Portfolio Management's Charles River Laboratories position peaked at $65.9M in Q1 2024.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q1 2026, filed 8 May 2026.